Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Use index funds for low-cost, long-term growth and simplicity; turn to mutual funds when you want active management and potential outperformance.
20,843 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
A frail, aging pool turned into a financial nightmare for a Texas widow. This story digs into how costs balloon, how ...
Record Prime Day spending climbs, yet the average purchase shrinks. The pattern signals growing financial pressure on...
JPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
With SPY's yield hovering near 1% and valuations high, investors are turning to covered calls to generate cash flow. ...
Oracle's AI strategy is under scrutiny as earnings shed light on backlog and cash needs. We see roughly 46-47% upside...
A rising Medicare surcharge tied to two-year look-back income means some inheritors face unexpectedly higher bills. T...
A powerful shift is forming: auto plants turning into energy storage hubs to power data centers and grids. This unsto...
New disclosures and reports tie Axon shares to a high-profile purchase before a major federal contract, prompting scr...
Arkansas plans to implement a SNAP candy-and-soda ban starting Wednesday, defying a federal court ruling that blocked...
U.S. regulators move to clear the way for civilian supersonic flights over the continental United States, setting noi...
Florida launches a staged crackdown on crypto ATMs, requiring warnings, receipts, caps, and a 72-hour refund for firs...